Ofer Sharon
Directeur Général chez OncoHost Ltd.
Profil
Ofer Sharon is currently the Chief Executive Officer at OncoHost Ltd.
and the President & Director at Valera Health, Inc. He previously worked as a Principal at Roche Pharmaceuticals, Inc., Vice President-Medical Development at NanoPass Technologies Ltd., and Principal at Notal Vision Ltd.
Sharon completed his undergraduate degree at Tel-Aviv University.
Postes actifs de Ofer Sharon
| Sociétés | Poste | Début |
|---|---|---|
Valera Health, Inc.
 Valera Health, Inc. Packaged SoftwareTechnology Services Valera Health, Inc. provides healthcare management software development services. The company was founded by Thomas Tsang and Ofer Sharon and is headquartered in Brooklyn, NY. | President | - |
OncoHost Ltd.
 OncoHost Ltd. Miscellaneous Commercial ServicesCommercial Services OncoHost Ltd. is an Israeli technology company that combines life-science research and advanced machine learning technology to develop personalized strategies to maximize the success of cancer therapy. The company utilizes proprietary proteomic analysis to understand a patient's unique response to therapy and overcome resistance to therapy. OncoHost's host response profiling platform (Prophet®) analyzes proteomic changes in blood samples to monitor the dynamics of biological processes induced by the patient in response to a given cancer therapy. OncoHost was founded in 2017, and the CEO is Ofer Sharon. | Directeur Général | - |
Anciens postes connus de Ofer Sharon
| Sociétés | Poste | Fin |
|---|---|---|
Roche Pharmaceuticals, Inc.
 Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Notal Vision Ltd.
 Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | Corporate Officer/Principal | - |
NanoPass Technologies Ltd.
 NanoPass Technologies Ltd. Pharmaceuticals: MajorHealth Technology NanoPass Technologies Ltd. develops and manufactures pharmaceuticals. It offers MicronJet needle which is a painless Intradermal Injection. The company was founded by Shuki Yeshurun in 2000 and is headquartered in Ness Ziona, Israel. | Directeur Technique/Scientifique/R&D | - |
Formation de Ofer Sharon
| Tel-Aviv University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Roche Pharmaceuticals, Inc.
Roche Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Roche Pharmaceuticals provides research and development services in the fields of pharmaceuticals and diagnostics. It also provides diagnostics and drugs for cancer and transplantation. The company is headquartered in Nutley, NJ. | Commercial Services |
NanoPass Technologies Ltd.
NanoPass Technologies Ltd. Pharmaceuticals: MajorHealth Technology NanoPass Technologies Ltd. develops and manufactures pharmaceuticals. It offers MicronJet needle which is a painless Intradermal Injection. The company was founded by Shuki Yeshurun in 2000 and is headquartered in Ness Ziona, Israel. | Health Technology |
Notal Vision Ltd.
Notal Vision Ltd. Medical/Nursing ServicesHealth Services Notal Vision Ltd. develops and manufactures computerized ophthalmic diagnostic devices. It develops age-related macular degeneration (AMD) monitor for patients at risk of vision loss from the devastating effects of wet AMD. The firm provides Preferential Hyperacuity Perimetry, a technology with clinical data for monitoring patients with AMD to eye care professionals. Its products are used for the detection and characterization of central and paracentral metamorphopsia in patients as an aid in monitoring progression of disease factors causing metamorphopsia, such as choroidal neovascularization. The company was founded in 2000 by Barak Azmon and Yair Alster and is headquartered in Tel Aviv, Israel. | Health Services |
OncoHost Ltd.
OncoHost Ltd. Miscellaneous Commercial ServicesCommercial Services OncoHost Ltd. is an Israeli technology company that combines life-science research and advanced machine learning technology to develop personalized strategies to maximize the success of cancer therapy. The company utilizes proprietary proteomic analysis to understand a patient's unique response to therapy and overcome resistance to therapy. OncoHost's host response profiling platform (Prophet®) analyzes proteomic changes in blood samples to monitor the dynamics of biological processes induced by the patient in response to a given cancer therapy. OncoHost was founded in 2017, and the CEO is Ofer Sharon. | Commercial Services |
Valera Health, Inc.
Valera Health, Inc. Packaged SoftwareTechnology Services Valera Health, Inc. provides healthcare management software development services. The company was founded by Thomas Tsang and Ofer Sharon and is headquartered in Brooklyn, NY. | Technology Services |
